Neurocrine Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of NBIX for the last quarter is 515.20 M USD, and it's 3.29% higher compared to the previous quarter. The net income of Q4 23 is 147.70 M USD.